| L Mark Gustafson, MD | |
|
150 Clinic Ave, Suite 201, Carrollton, GA 30117-4401 | |
| (770) 832-1488 | |
| Not Available |
| Full Name | L Mark Gustafson |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 28 Years |
| Location | 150 Clinic Ave, Carrollton, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073555629 | NPI | - | NPPES |
| 841043 | Other | GA | BLUE CROSS CLUE SHIELD |
| 00906463C | Medicaid | GA | |
| 00906463B | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 049795 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tanner Medical Center - Carrollton | Carrollton, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tanner Medical Group | 2769536143 | 98 |
News Archive
Six states voted for candidates Tuesday to run for congressional and Senate seats. Some viewed these contests as important to watch because they highlighted face-offs between the GOP establishment and its tea party wing.
Cardiovascular clinical trials published between 2000 and 2005 were significantly more likely to report positive findings if they were funded by for-profit organizations than those funded by not-for-profit organizations
Aires Pharmaceuticals Inc. today announced the signing of an exclusive license agreement with the U.S. National Institutes of Health for the patented use of a nitric oxide prodrug to treat cardiopulmonary conditions.
Researchers at the University of North Carolina at Chapel Hill have discovered a molecule that can make brain cells resistant to programmed cell death or apoptosis.
› Verified 8 days ago
| Entity Name | Carrollton Ear Nose And Throat Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410401 PECOS PAC ID: 3577558931 Enrollment ID: O20040416000289 |
News Archive
Six states voted for candidates Tuesday to run for congressional and Senate seats. Some viewed these contests as important to watch because they highlighted face-offs between the GOP establishment and its tea party wing.
Cardiovascular clinical trials published between 2000 and 2005 were significantly more likely to report positive findings if they were funded by for-profit organizations than those funded by not-for-profit organizations
Aires Pharmaceuticals Inc. today announced the signing of an exclusive license agreement with the U.S. National Institutes of Health for the patented use of a nitric oxide prodrug to treat cardiopulmonary conditions.
Researchers at the University of North Carolina at Chapel Hill have discovered a molecule that can make brain cells resistant to programmed cell death or apoptosis.
› Verified 8 days ago
| Entity Name | Tanner Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396979787 PECOS PAC ID: 2769536143 Enrollment ID: O20090819000657 |
News Archive
Six states voted for candidates Tuesday to run for congressional and Senate seats. Some viewed these contests as important to watch because they highlighted face-offs between the GOP establishment and its tea party wing.
Cardiovascular clinical trials published between 2000 and 2005 were significantly more likely to report positive findings if they were funded by for-profit organizations than those funded by not-for-profit organizations
Aires Pharmaceuticals Inc. today announced the signing of an exclusive license agreement with the U.S. National Institutes of Health for the patented use of a nitric oxide prodrug to treat cardiopulmonary conditions.
Researchers at the University of North Carolina at Chapel Hill have discovered a molecule that can make brain cells resistant to programmed cell death or apoptosis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| L Mark Gustafson, MD 150 Clinic Ave, Suite 201, Carrollton, GA 30117-4401 Ph: (770) 832-1488 | L Mark Gustafson, MD 150 Clinic Ave, Suite 201, Carrollton, GA 30117-4401 Ph: (770) 832-1488 |
News Archive
Six states voted for candidates Tuesday to run for congressional and Senate seats. Some viewed these contests as important to watch because they highlighted face-offs between the GOP establishment and its tea party wing.
Cardiovascular clinical trials published between 2000 and 2005 were significantly more likely to report positive findings if they were funded by for-profit organizations than those funded by not-for-profit organizations
Aires Pharmaceuticals Inc. today announced the signing of an exclusive license agreement with the U.S. National Institutes of Health for the patented use of a nitric oxide prodrug to treat cardiopulmonary conditions.
Researchers at the University of North Carolina at Chapel Hill have discovered a molecule that can make brain cells resistant to programmed cell death or apoptosis.
› Verified 8 days ago
Dr. William Bradley Gambrell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 150 Clinic Ave, Suite 201, Carrollton, GA 30117 Phone: 770-832-1488 | |
John C Pezold, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 150 Clinic Ave, Suite 201, Carrollton, GA 30117 Phone: 770-832-1488 |